Install
- 2,454articles · 30d
- 5+ hour agolatest article
- Aug 15, 2026earliest in window
- 92%with images
- 146avg words
- Economy, Business & Finance 2,395
- Finance & Business 2,186
- News 1,550
- Business & Industrial 497
- Finance 330
- Industrial 222
- Medical 21
- Health & Wellness 21
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Extendicare and the Changing Healthcare Services Landscape
1+ day, 9+ hour ago (43+ words) Kalkine Media Premium Brands Holdings in Focus Across Canada’s Food Processing Restaurant Brands International: Business Profile and TSX Market Saputo and the Changing Food Processing Landscape Sleep Country Canada Holdings in Focus Across Canada’s Retail Se...
Optiscan Imaging Completes Imaging of 84 Cases in ACL Digital Pathology Collaboration
4+ day, 2+ hour ago (68+ words) kalkinemedia.com Optiscan Imaging Ltd (ASX:OIL) OIL (ASX:OIL) has announced that its clinical collaboration with Australian Clinical Labs (ACL) has successfully imaged 84 cases using the InForm14 digital pathology imaging system. These cases encompass a wide variety of human tissue…...
Onco-Innovations Shares Interim Liver Microsome Metabolism Data for ONC010 PNKP Inhibitor in Human, Rat, and Dog Models
4+ day, 14+ hour ago (37+ words) Kalkine Media Lightspeed Commerce (TSX:LSPD) Tech Stock Latest Update Kinaxis (TSX:KXS) Faces Key Growth Questions Ahead Growth Stocks...
EBR Systems Confirms No FDA Recall Needed After WiSE System Cybersecurity Review
5+ day, 6+ hour ago (68+ words) Kalkine Media EBR Systems (ASX:EBR) EBR (ASX:EBR), the creator of a wireless cardiac pacing device designed for heart failure patients, announced that the U.S. Food and Drug Administration has completed its review of the company's cybersecurity risk assessment and…...
Actinogen Medical's CMO Highlights Xanamem Research at Global Neuroscience Event in Paris
5+ day, 6+ hour ago (88+ words) Growing Dividends Could Matter More Than High ASX Yields Lynas Rare Earths Earnings: What Has Changed for (ASX:LYC)? Australian Penny Stocks: 3 Companies in Focus This September Red Hill Minerals (ASX:RHI) Results: Strong Profits, Tighter Margins Actinogen Medical (ASX:…...
Filament Health Delivers PEX010 to Australia for Groundbreaking Psilocybin-Assisted Physiotherapy Trial in Functional Neurological Disorder
5+ day, 14+ hour ago (44+ words) Kalkine Media What Makes WELL Health Technologies Corp. (TSX:WELL) Stand Out? Why Is Tilray Brands Inc. (TSX:TLRY) In Focus? Why Is TELUS Corporation (TSX:T) Making Headlines?...
Racura Oncology’s RC220 MYC-Silencing Preclinical Findings Accepted for 2026 Frontiers in Cancer Science Conference in Singapore
6+ day, 10+ hour ago (98+ words) Kalkine Media CSL (ASX:CSL): What’s Behind Its Global Healthcare Footprint? Why Is Lovisa (ASX:LOV) Still Turning Heads Across Retail Stocks? Racura Oncology (ASX:RAC) RAC (ASX:RAC) has been invited to present preclinical research on its RC220 drug candidate…...
Novo Nordisk's STEP Young Phase 3 Trial Shows Semaglutide Significantly Reduces Obesity in Children Aged 6 to Under 12
6+ day, 18+ hour ago (21+ words) Kalkine Media...
Arovella Therapeutics Unveils First Clinical Batch of ALA-101 and Launches Initial Trial Site at The Alfred
1+ week, 10+ hour ago (94+ words) Kalkine Media Why Is WiseTech Global (ASX:WTC) in Focus? What Changed for BHP (ASX:BHP) Dividends After Results? Why Is CSL (ASX:CSL) Back on Dividend Watch? Arovella Therapeutics (ASX:ALA) ALA (ASX:ALA) has successfully manufactured and released…...
Kane Biotech (TSX-V: KNE) Unlocks Ontario Health atHome Formulary Access Through OMS Partnership
1+ week, 11+ hour ago (315+ words) Millions of patients. Tens of millions of nursing visits. And at the center of it all, a stubborn clinical challenge that drains resources and resists conventional treatment. Kane Biotech (TSX-V:KNE) is moving decisively into this space, and its latest…...